Lactate Dehydrogenase and Severity of Pain in Children with Sickle Cell Disease

被引：11

作者：

Najim, Oula Abdullah ^{[2
]}

Hassan, Mea'ad Kadhum ^{[1
]}

机构：

[1] Univ Basrah, Dept Pediat, Coll Med, Basrah, Iraq

[2] Basrah Matern & Children Hosp, Basrah, Iraq

来源：

ACTA HAEMATOLOGICA | 2011年 / 126卷 / 03期

关键词：

Children; Lactate dehydrogenase; Pain; Sickle cell disease;

D O I：

10.1159/000328416

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: This prospective study was carried out to assess lactate dehydrogenase (LDH) as a biochemical marker during acute painful episode and steady state in children with sickle cell disease (SCD). Design and Methods: A prospective descriptive study has been carried out on children and adolescents with SCD and pain during a vaso-occlusive episode. A total of 76 patients aged 1-18 years were included. Assessment of pain was done using the suitable pain assessment tool (visual analogue scales, Oucher scale) for school and preschool children. Complete blood count, liver function tests, LDH and C-reactive protein assay were performed on all patients during acute painful episode and steady state. Results: LDH has been found to increase significantly during acute painful episode compared with steady state (p < 0.01). There is also a significant positive correlation between LDH level and severity of pain (p < 0.05). In addition, C-reactive protein level was found to be significantly elevated during acute painful episode (p < 0.01) and its level correlates significantly with severity of pain (p = 0.01). Conclusion: From this study it can be concluded that LDH is a significant biochemical marker for the severity of pain during a vaso-occlusive episode in SCD. Copyright (C) 2011 S. Karger AG, Basel

引用

页码：157 / 162

页数：6

共 23 条

[1]

Al Arrayed SS, 1995, East Mediterr Health J, V1, P112, DOI [10.26719/1995.1.1.112, DOI 10.26719/1995.1.1.112]

[2]

Ballas Samir K, 2007, Hematology Am Soc Hematol Educ Program, P97

[3] Evidence-based assessment of pediatric pain [J].